-
1Academic Journal
المؤلفون: A. Vasileva A., V. Krivitskaya Z., E. Vojcekhovskaya M., V. Vakin S., E. Kuznecova V., E. Petrova R., A. Go A., N. Lvov I., A. Sominina A., А. Васильева А., В. Кривицкая З., Е. Войцеховская М., В. Вакин С., Е. Кузнецова В., Е. Петрова Р., А. Го А., Н. Львов И., А. Соминина А.
المصدر: Epidemiology and Vaccinal Prevention; Том 15, № 2 (2016); 77-84 ; Эпидемиология и Вакцинопрофилактика; Том 15, № 2 (2016); 77-84 ; 2619-0494 ; 2073-3046 ; 10.31631/2073-3046-2016-15-2
مصطلحات موضوعية: инактивированные гриппозные вакцины, пандемический грипп A(H1N1)pdm09, гуморальный иммунитет, изотипы иммуноглобулинов, взрослые волонтеры, переболевшие гриппом пациенты, inactivated influenza vaccines, pandemic influenza A(H1N1)pdm09, humoral immunity, immunoglobulin isotypes, adult volunteers, recover from influenza patients
وصف الملف: application/pdf
Relation: https://www.epidemvac.ru/jour/article/view/153/154; Chiu C., Ellebedy A.H., Wrammert J., Ahmed R. B cell responses to influenza infection and vaccination. Curr. Top. Microbiol. Immunol. 2015; 386: 381-398.; Gomez Lorenzo M.M., Fenton M. J. Immunobiology of influenza vaccines. Chest. 2013; 143 (2): 502 - 510.; Chung E.H. Vaccine allergies. Clin. Exp. Vaccine. Res. 2014; 3 (1): 50 - 57.; Lv J., Wang D., Hua Y.H., Pei S.J., Wang J., Hu W.W. et al. Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice. BMC Infect Dis. 2014; 14: 197.; Ельшина Г.А., Лонская Н.И., Мефед К.М., Пучкова Н.Г., Чирун Н.В., Горбунов М.А. и др. Результаты клинических исследований пандемических субъединичных гриппозных моновакцин. Биопрепараты. 2010; 4 (40): 31 - 36.; Ельшина Г.А., Харит С.М., Романенко В.В., Комлева С.В., Пучкова Н.Г., Чирун Н.В. и др. Результаты изучения безопасности и иммуногенности отечественных субъединичных адъювантных пандемических моновакцин группы Гриппол® у детей от 6 месяцев до 17 лет. Эпидемиология и Вакцинопрофилактика. 2011; 2 (57): 41 - 46.; Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 1 (72): 248 - 254.; Соминина А.А., Кривицкая В.З., Войцеховская Е.М., Медведева Н.А., Липина Н.В., Потапенко Л.Б. Практические рекомендации по диагностике вирусных инфекций. Санкт-Петербург: 2005: 21.; Palladino G., Mozdzanowska K., Washko G., Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 1995; 69(4): 2075 - 2081.; Pedersen G.K., H schler K., ie Solbak S.M., Bredholt G., Pathirana R.D., Afsar A. et al. Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine. 2014; 32 (35): 4550 - 4557.; El-Madhun A.S., Cox R.J., Haaheim L.R. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J Infect Dis. 1999; 180 (4): 1356 - 1360.; Frasca D., Diaz A., Romero M., Mendez N., Landin A.M., Blomberg B. Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011 -2012 influenza vaccine season. Immunity and Ageing. 2013; 10:14.; Arankalle V.A., Lole K.S., Arya R.P., Tripathy A.S., Ramdasi A.Y., Chadha M.S. et al. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One. 2010; 5(10): e13099.; Concept paper on the revision of the CPMP/BWP note for guidance on harmonization of requirements for influenza vaccines. London; 2001, CPMP/ EWP/1045/01.; Vidarsson G., Dekkers G., Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front. Immunol. 2014; 5: 520.; Reichert T., Chowell G., Nishiura H., Christensen R.A., McCullers J.A. Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BioMed. Central. Infect. Dis. 2010; 10: 5 - 9.; Gordon C.L., Johnson P.D., Permezel M., Holmes N.E., Gutteridge G., McDonald C.F. et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin. Infect. Dis. 2010; 50 (5): 672 - 678.; Yamamoto T., Mizoguchi Y., Kaneno H., Yamamoto K., Inoue Y., Kawashima H. et al. Serum immunoglobulin G subclass levels and estimated clinical severity caused by possible influenza A(H1N1)pdm2009 infection. J. Infect. Chemother. 2013; 19: 833 - 842.; Burton O.T., Oettgen H.C. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol. Rev. 2011; 242 (1): 128 - 143.; Hofmaier S., Comberiati P., Matricardi P.M. Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy. Eur. Ann. Allergy. Clin. Immunol. 2014; 46 (1): 6 - 11.; Smith-Norowitz T.A., Kusonruksa M., Wong D., Norowitz M.M., Joks R., Durkin H.G. et al. Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study. J. Inflamm Res. 2012; 5: 111 - 116.; Julkunen I., Hovi T., Seppl I., M kel O. Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin. Exp. Immunol. 1985; 60 (1): 130 - 138.; Monteiro R.C. Role of IgA and IgA fc receptors in inflammation. J. Clin. mmunol. 2010; 30 (1): 1 - 9.; Li Z.N., Lin S.C., Carney P.J., Li J., Liu F., Lu X. et al. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States. Clin. Vaccine. Immunol. 2014; 21 (8): 1054 - 1060.; https://www.epidemvac.ru/jour/article/view/153